Concentration Approaches for mRNA and mRNA–LNP Formulations: Enabling mRNA Integrity Quantification in Low‐Concentration Formulations
ELECTROPHORESIS · 2026
DOI: 10.1002/elps.70076 ↗Kurz gefasst
Fachartikel in der Zeitschrift ELECTROPHORESIS, 2026. Verfasst von Shang-Yin Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: RNA, Messenger, Nanoparticles, Lipids. Die Arbeit nennt 28 Literaturangaben. Gefördert von: the Huadong Medicine Joint Funds of the Zhejiang Provincial Natural Science Foundation of China, Taizhou Science and Technology Plan Projects, Jinhua Science and Technology Plan Projects.
Abstract (Originalsprache)
mRNA‐based vaccines and self‐amplifying mRNA (saRNA) have gained growing attention for disease prevention and treatment, but precise detection of low‐concentration RNA (including mRNA–lipid nanoparticles, mRNA–LNPs) stability and integrity remains challenging—limiting quality control of RNA‐based therapeutics. Capillary electrophoresis (CE)‐based instruments show potential, yet suitable concentration strategies for low‐abundance, labile RNAs are lacking. This study established two distinct concentration methods (freeze‐drying and ultrafiltration) applicable to mRNA, mRNA–LNPs, and saRNA formulations, enabling the conversion of dilute solutions to high‐concentration preparations while preserving the structural and molecular integrity of the target nucleic acids. Subsequent stability evaluations and conventional high‐performance liquid chromatography analyses of the concentrated products verified their superior storage stability and strong practical applicability. This article aims to reduce the difficulty of RNA integrity assessment and improve the accuracy of detecting various low‐concentration RNA samples that may arise in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
- Innovation Center of Translational Pharmacy, Jinhua Institute of Zhejiang University, Jinhua, China.
- Taizhou Institute of Zhejiang University, Taizhou, China.
- Immorna Biotechnology Co., Ltd, Hangzhou, China.
- Junjian Biotechnology Co., Ltd, Ningbo, China.
- School of Pharmacy, China Pharmaceutical University, Nanjing, China.
Förderung
- the Huadong Medicine Joint Funds of the Zhejiang Provincial Natural Science Foundation of China
- Taizhou Science and Technology Plan Projects
- Jinhua Science and Technology Plan Projects
- Municipal-University Cooperation Projects of Taizhou Institute of Zhejiang University
- Zhejiang Key Laboratory of Biopharmaceutical Contact Materials
- State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory
Zitieren
APA
Wu, S. Y., He, Y. J., Guo, Z. J., Wang, M., Xiong, C. Y., Hou, T., Di, B., & Fang, W. J. (2026). Concentration Approaches for mRNA and mRNA–LNP Formulations: Enabling mRNA Integrity Quantification in Low‐Concentration Formulations. ELECTROPHORESIS. https://doi.org/10.1002/elps.70076
Vancouver
Wu SY, He YJ, Guo ZJ, Wang M, Xiong CY, Hou T, et al. Concentration Approaches for mRNA and mRNA–LNP Formulations: Enabling mRNA Integrity Quantification in Low‐Concentration Formulations. ELECTROPHORESIS. 2026. doi:10.1002/elps.70076
BibTeX
@article{Wu2026,
author = {Wu, Shang-Yin and He, Yun-Jie and Guo, Zhi-Jun and Wang, Min and Xiong, Chang-Yun and Hou, Tingjun and Di, Bin and Fang, Wei-Jie},
title = {Concentration Approaches for mRNA and mRNA–LNP Formulations: Enabling mRNA Integrity Quantification in Low‐Concentration Formulations},
journal = {ELECTROPHORESIS},
year = {2026},
doi = {10.1002/elps.70076}
}
EUVIMED